MAPT and cancer: The link between Tau and the P53-MDM2 axis may likely explain the de-regulation of the P53 pathway and other P53- and/or MDM2-dependent signaling in neurodegeneration as well as the observed correlations between multiple aspects of cancer and MAPT expression.